Trial Information

Summary: Bradenton Neurology, Inc. is participating in a nationwide research study for individuals who have been diagnosed with Multiple Sclerosis.

If you are between 18 and 55 years of age, have been receiving Avonex therapy for at least 6 months, and have experienced a relapse of some type during the past 12 months, you may qualify for this study.

Participants will receive all study-related care and procedures by a Board Certified Neurologist at no cost.

For more information, please contact us.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:09 AM